Deep Sail Capital on X
$MAMA is probably at the most attractive valuation since 3 years ago. And right as they are executing super well. This will be a couple billon dollar company in a few years.
Sector
Consumer Staples
Everything our editor has picked under this sector, best first.
242 stories
DOMO Capital Management, LLC on X
Not good for corn / corn basis. Good for $ALTO $GPRE https://t.co/Vv0h05uhzy
DOMO Capital Management, LLC on X
$ALTO StoneX initiates with a Buy rating and $7 price target: https://t.co/AnUoeGvT6X
Colin King on X
$CALM down ~8% pre-market on 1Q27 results Likely another few quarters til cycle turn (?), balance sheet still rock solid, minimal buybacks, dividend is variable so no payout when losing money $55/sh BV (~$50 TBV) vs. $63 pre-market = 1.15x P/B https://t.co/Xx0kmu7j66
💥Yield!💥
Beyond Meat’s Q2 2026 revenue fell 8.2% as U.S. retail and foodservice volumes declined, while a flatter, not inverted, Treasury curve…
Kimberly-Clark's Dividend And Safe Haven Trade Outweigh Post-Merger Risks
Kimberly-Clark's 5% dividend yield and Kenvue merger upside outweigh Tylenol litigation risk after a 30% share-price decline.
Undiscovered Compounders on X
442,113,600%. That's how much Altria has compounded over the past 100 years. $MO Remove Altria from the average return of every US stock since 1926, and the average gets cut in half: from 30,000% to 15,000%. What's stopping you from compounding like that?
Dalius - Special Sits on X
@lazereater You can read about $LWAY drama here: https://t.co/gEWWLrfgXV
Shake Shack: The Perfect Storm For A 2027 Breakout
Shake Shack combines 23% restaurant-level margins, 703 locations and positive free cash flow; the bullish thesis targets $4 billion…
Security Analysis 1 click
Campbell's: Profit Continues To Fall, But The Stock Is Becoming Interesting
Campbell’s $500 million savings program and Rao’s growth could lift EBIT despite weak FY2027 guidance, while volume declines and inflation…
Investor Overview Calvin Blissett on X
$TLRY: I picked because they have Montauk beer, a brand I am super familiar (lol losing braincells scuttlebutt) with because of where I live so it piqued my interest. Secular beer decline will not affect this brand, it is a premium brand and will stay so catering to the wealthiest people on the planet (Hamptons). GAAP losses and dilution, federal rescheduling of cannabis could be huge: By holding onto those 15 to 18 inactive asset pieces (MedMen Stores/Licenses) right now, Tilray owns a massive pipeline of U.S. cannabis real estate that costs them almost nothing to maintain today, but will command a massive premium the moment the federal government finalizes the Schedule III transition. CEO got no performance bonus in 26' bc missed targets. At Friday's $4.13 close, market cap is about $566M and current enterprise value is about $733M. global cannabis + beverage platform trading at ~12x FY26 adjusted EBITDA, with international cannabis +34%, Germany driving growth, FY26 revenue +11% and EBITDA +11%, 275MT annual cannabis capacity, and BrewDog acquired out of administration for ~£33M + subsequent U.S./Australia assets; 14.4% of float short.
Barbarian Capital on X
General Mills Profit, Sales Slip as Turnaround Continues $GIS https://t.co/hCadtnVNZ8
Barbarian Capital on X
$PM $BTI $MO U.S. Regulators Plan Major Move to Speed Authorizations of Vapes, Tobacco Pouches https://t.co/aaQ7DSzIvP
Turning Point Brands: The Market Is Now Overly Concerned (Rating Upgrade)
Turning Point Brands reaffirmed 2026 guidance after a CEO change, while ALP and FRE expansion has compressed margins through marketing and…
Caffital Research 1 clickUndiscovered Compounders on X
@EmmaStockNotes Purely eye candy: the biggest compounder is Altria $MO at 442,100,000%. Strip Altria out of the average and it drops to about 15,000%, roughly cut in half.
Colin King on X
$TPB starting to round trip here... way off its early 2026 highs haven't been following this since mid-2025, help me catch up on what's happening lately? https://t.co/HcsiMJXkuq
Ian Bezek on X
@Tintincapital @valuehurts Has already happened, no? The $WING and $CAVA style restaurant growth stories have collapsed. Or look at something like Vail Resorts, down 65% off the 2022 peak.
Barbarian Capital on X
Hot Honey no, thanks good buzz for $HRL tho https://t.co/ythkEhbNVK
Calvin Blissett on X
$ARKO Trading below the value of it's stake in $APC, transferring to asset light business model, targeting 10% dividend https://t.co/kDZ2zPoIkm
Maj Soueidan on X
Joke Of The Week award goes to $UPXI👇 Year end “highlights” from press release: - Repurchased 2.9M shares. - Subsequent to fiscal year-end, issued 2.5M shares under the company’s at-the-market program. Punch line: Now that’s what capital allocation looks like baby!
Asif Suria on X
Yes these Celsius $CELH purchases certainly stood out when we were looking at insider buys this week. They were also buying at similar prices in May. Although those Nov 2025 purchases by the same director that was buying this week (Hal Kravitz) and by their COO were not timed well. Kravitz was previously a Coca Cola executive and has been on Celsius' board for over 10 years. We usually like to see opportunistic insider purchases by independent directors with long tenure on the board.
Groceries, Aggregators, and Agents
DoorDash's grocery push targets a shift from weekly stock-up trips to frequent online fill-in orders, though smaller baskets complicate…
Diamond Estates: Research Note
Diamond Estates Wines & Spirits plans to expand grocery and export sales, invest in six brands, and improve winery operations through FY29.
KEDM.com on X
Greenhaven Road @GreenhavenRoad took a full position in Burford Capital $BUR on the economics of its protein price-fixing book: Burford has put more than $150m of its own capital into the chicken, beef, turkey and pork cases, so it keeps all of the upside rather than sharing it with a client and it controls when the cases settle. The track record behind that underwriting: 285+ concluded cases, 90% won or profitably settled, an 82% return on invested capital over a 2.6-year weighted average life for a 25% IRR. The catalyst is dated — the chicken trial against Tyson Foods, Pilgrim's Pride, Koch Foods and Cargill is set for 2027.
